Distinct Changes in Gut Microbiota of Patients With Kidney Graft Rejection

Background. Kidney graft rejection still represents the major cause of graft loss in kidney transplant recipients. Of growing interest is the bidirectional relationship between gut microbiome and immune system suggesting that gut microbiota can affect allograft outcome. Methods. In this cross-sectio...

Full description

Bibliographic Details
Main Authors: Vanessa Visconti, MD, Stefan Wirtz, PhD, Mario Schiffer, MD, Janina Müller-Deile, MD
Format: Article
Language:English
Published: Wolters Kluwer 2024-03-01
Series:Transplantation Direct
Online Access:http://journals.lww.com/transplantationdirect/fulltext/10.1097/TXD.0000000000001582
_version_ 1797292770033926144
author Vanessa Visconti, MD
Stefan Wirtz, PhD
Mario Schiffer, MD
Janina Müller-Deile, MD
author_facet Vanessa Visconti, MD
Stefan Wirtz, PhD
Mario Schiffer, MD
Janina Müller-Deile, MD
author_sort Vanessa Visconti, MD
collection DOAJ
description Background. Kidney graft rejection still represents the major cause of graft loss in kidney transplant recipients. Of growing interest is the bidirectional relationship between gut microbiome and immune system suggesting that gut microbiota can affect allograft outcome. Methods. In this cross-sectional case-control study, we characterized the gut microbial profile of adult renal transplant recipients with and without graft rejection to define a cohort-specific microbial fingerprint through 16S ribosomal RNA gene sequencing. We used very strict inclusion and exclusion criteria to address confounder of microbiota composition. Results. Different relative abundances in several gut microbial taxa were detectable in control patients compared with patients with kidney allograft rejection. Alpha diversity was lower in the rejection group and beta diversity revealed dissimilarity between patients with and without kidney graft rejection (P < 0.01). When the rejection group was stratified according to different types of allograft rejection, major changes were identified between patients with chronic T-cellular–mediated rejection and controls. Changes in alpha diversity within the gut microbiome were related to the probability of chronic T-cellular–mediated rejection (P < 0.05). Kidney transplant patients without rejection showed significant enrichment of rather anti-inflammatory taxa whereas in the rejection group bacteria well known for their role in chronic inflammation were increased. For example, amplicon sequence variant (ASV) 362 belonging to the genus Bacteroides and ASV 312 belonging to Tannerellaceae were enriched in no rejection (P < 0.001 and P < 0.01), whereas ASV 365 was enriched in patients with allograft rejection (P = 0.04). Looking at metagenomic functions, a higher abundance of genes coding for enzymes involved in bacterial multidrug resistance and processing of short-chain fatty acids was found in patients without rejection but an increase in enzymes involved in nicotinamide adenine dinucleotide phosphate production was seen in patients with allograft rejection. Conclusions. A distinct microbial fingerprint of patients with allograft rejection might serve as noninvasive biomarker in the future.
first_indexed 2024-03-07T20:01:21Z
format Article
id doaj.art-a2b419e5dd9041aeb5f298ee0b597ad5
institution Directory Open Access Journal
issn 2373-8731
language English
last_indexed 2024-03-07T20:01:21Z
publishDate 2024-03-01
publisher Wolters Kluwer
record_format Article
series Transplantation Direct
spelling doaj.art-a2b419e5dd9041aeb5f298ee0b597ad52024-02-28T06:50:07ZengWolters KluwerTransplantation Direct2373-87312024-03-01103e158210.1097/TXD.0000000000001582202403000-00005Distinct Changes in Gut Microbiota of Patients With Kidney Graft RejectionVanessa Visconti, MD0Stefan Wirtz, PhD1Mario Schiffer, MD2Janina Müller-Deile, MD31 Department of Nephrology, University Hospital Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany.3 Medical Department 1, University Hospital Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany.1 Department of Nephrology, University Hospital Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany.1 Department of Nephrology, University Hospital Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany.Background. Kidney graft rejection still represents the major cause of graft loss in kidney transplant recipients. Of growing interest is the bidirectional relationship between gut microbiome and immune system suggesting that gut microbiota can affect allograft outcome. Methods. In this cross-sectional case-control study, we characterized the gut microbial profile of adult renal transplant recipients with and without graft rejection to define a cohort-specific microbial fingerprint through 16S ribosomal RNA gene sequencing. We used very strict inclusion and exclusion criteria to address confounder of microbiota composition. Results. Different relative abundances in several gut microbial taxa were detectable in control patients compared with patients with kidney allograft rejection. Alpha diversity was lower in the rejection group and beta diversity revealed dissimilarity between patients with and without kidney graft rejection (P < 0.01). When the rejection group was stratified according to different types of allograft rejection, major changes were identified between patients with chronic T-cellular–mediated rejection and controls. Changes in alpha diversity within the gut microbiome were related to the probability of chronic T-cellular–mediated rejection (P < 0.05). Kidney transplant patients without rejection showed significant enrichment of rather anti-inflammatory taxa whereas in the rejection group bacteria well known for their role in chronic inflammation were increased. For example, amplicon sequence variant (ASV) 362 belonging to the genus Bacteroides and ASV 312 belonging to Tannerellaceae were enriched in no rejection (P < 0.001 and P < 0.01), whereas ASV 365 was enriched in patients with allograft rejection (P = 0.04). Looking at metagenomic functions, a higher abundance of genes coding for enzymes involved in bacterial multidrug resistance and processing of short-chain fatty acids was found in patients without rejection but an increase in enzymes involved in nicotinamide adenine dinucleotide phosphate production was seen in patients with allograft rejection. Conclusions. A distinct microbial fingerprint of patients with allograft rejection might serve as noninvasive biomarker in the future.http://journals.lww.com/transplantationdirect/fulltext/10.1097/TXD.0000000000001582
spellingShingle Vanessa Visconti, MD
Stefan Wirtz, PhD
Mario Schiffer, MD
Janina Müller-Deile, MD
Distinct Changes in Gut Microbiota of Patients With Kidney Graft Rejection
Transplantation Direct
title Distinct Changes in Gut Microbiota of Patients With Kidney Graft Rejection
title_full Distinct Changes in Gut Microbiota of Patients With Kidney Graft Rejection
title_fullStr Distinct Changes in Gut Microbiota of Patients With Kidney Graft Rejection
title_full_unstemmed Distinct Changes in Gut Microbiota of Patients With Kidney Graft Rejection
title_short Distinct Changes in Gut Microbiota of Patients With Kidney Graft Rejection
title_sort distinct changes in gut microbiota of patients with kidney graft rejection
url http://journals.lww.com/transplantationdirect/fulltext/10.1097/TXD.0000000000001582
work_keys_str_mv AT vanessaviscontimd distinctchangesingutmicrobiotaofpatientswithkidneygraftrejection
AT stefanwirtzphd distinctchangesingutmicrobiotaofpatientswithkidneygraftrejection
AT marioschiffermd distinctchangesingutmicrobiotaofpatientswithkidneygraftrejection
AT janinamullerdeilemd distinctchangesingutmicrobiotaofpatientswithkidneygraftrejection